Anne Liu (@AnneLiuMD) profile picture

The Bugs, the Drugs, and the Cells. Immunocompromised host infectious diseases physician. Allergist/immunologist. Stanford, CA.

Joined October 2013
Photo by Anne Liu (@AnneLiuMD)Photo by Anne Liu (@AnneLiuMD)Photo by Anne Liu (@AnneLiuMD)Photo by Anne Liu (@AnneLiuMD)Photo by Anne Liu (@AnneLiuMD)
Will omalizumab do to food oral immunotherapy what dupilumab did to aspirin desensitization? #AAAAI24
2
96
The only antibody therapy known to neutralize SARS-CoV-2 variants XBB.1 BQ.1.1 in vitro + available under FDA EUA for immunocompromised COVID is convalescent plasma from vaccinated/boosted donors. Grateful to @giveblood for making CCP available!
4
213
We are so excited to gain such an incredible new class of incoming fellows today! Congratulations to each of you on all you have already accomplished. We cannot wait for you to join our Stanford ID family in a few short months!
9
15
9
96
Great news! Novavax COVID-19 vaccine just got authorized for 1st booster! Doesn’t matter what u got for 1st/2nd (primary series). Lots of ppl who had oddball symptoms after mRNA or J&J of unclear attribution have waited for this. Uses protein subunit tech, not mRNA.
1
2
Allergies are weird!! Thanks, @KatherineJWu, for “shedding” some light on cat allergies. The human body is a strange place. The more we learn, the stranger it gets. Glad your B cells and mast cells have made their peace with Calvin and Hobbes.
1
“Allergy…is a hot, complicated mess—a common fixture of modern living that many of us take for granted, but that remains, in so many cases, a mystery.” @KatherineJWu #AIMedEd @rubin_allergy @AnneLiuMD @nowak_wegrzyn theatlantic.com/science/arch…
1
5
1
15
Intradermal delivery of vaccines? Calling all allergy nurses!!
Replying to @kavitapmd
The DOWNSIDE of going from single to multi dose vials is wastage/also many of us in primary care still do PPD skin test (to test for TB) which is intradermal,but not all health workers are trained to do this.Nevertheless its an incredible boost for a dwindling supply of vax -fin
1
Novel COVID variants are likely arising from immunocompromised people. ~2-3% of the population is immunocompromised. ~100% of the population is impacted by novel variants. We need to invest in preventing infection in immunocompromised people — globally.
1